Press Releases September 17, 2025: MaaT Pharma Publishes its Half Year 2025 Results and Provides a Business Update MaaT Pharma Publishes its Half Year 2025 Results and Provides a Business Update Positive results…MaaT PharmaSeptember 17, 2025
Press Releases July 2nd, 2025: MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® in acute Graft-versus Host Disease in Europe MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® in acute Graft-versus Host Disease…MaaT PharmaJuly 2, 2025
